Specialty Active Pharmaceutical Ingredients Market
Market Insights on Specialty Active Pharmaceutical Ingredients covering sales outlook, demand forecast & up-to-date key trends
Specialty Active Pharmaceutical Ingredients Market By Product Type (Small Molecules API, Peptides API, Carbohydrate Drugs API, Steroidal Drugs API), Consumption (In-house, Outsourced) & Region - Forecast 2020 - 2030
Specialty Active Pharmaceutical Ingredients (API) Market Outlook & Key Findings
- Specialty active pharmaceutical ingredients (API) market likely to grow at over 7.0 % in 2020, as increasing patent expiry of various branded drugs boosts generics sales in the US and Europe
- Technological advancement in order to increase production capacity in API manufacturing providing high market potential for specialty active pharmaceutical ingredients (API) in developed markets
- Low-cost offerings from local players are putting pressures on profit margin of big companies
- Outbreak of COVID19 pandemic has also led to decrease in the production capability of various specialty API manufacturers including pharmaceutical companies and Contract Manufacturing Organization (CMOs)
Let us know your requirement to get
100% FREE customization
Development of New Purification Technologies Reducing the Production Cost-Factor
Advancement of analytical methods provides better quantification and characterization of the specialty APIs of interest that also reduce the time and production.
- For example, the introduction of new LC/MS methods in the last few years which use both - low levels of hexafluoroisopropanol (HFIP) and triethylamine (TEA) as a mobile-phase buffer, drive the purification processes and also reduce time and cost.
Besides, there has been significant development in proprietary chemical processes to scale up manufacturing capabilities that have greatly reduced the cost of producing specialty active pharmaceutical ingredients.
Expansion of Manufacturing Facilities Creating Lucrative Opportunities for Market Growth
Majority of specialty API companies are expanding their manufacturing facilities for specialty active pharmaceutical ingredients (API) to maintain or gain market share. Substantial investments in the expansion of approved specialty active pharmaceutical ingredients (API) is one of the major factors among key players in the specialty active pharmaceutical ingredients (API) market.
For instance, in early 2020, WuXi STA opened oligonucleotide API manufacturing facility in Changzhou, China to cope up with the increasing demand.
In 2018, Corden Pharma expanded operations with new commercial oligonucleotide active pharmaceutical ingredients (API) manufacturing capabilities at its FDA inspected Colorado facility.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystSpecialty Active Pharmaceutical Ingredients (API) Market is Highly Consolidated Among Key Players
The key market players of specialty active pharmaceutical ingredients (API) market are developing highly innovative approaches and business strategies in order to keep the market significantly consolidated.
The major players of the market are focusing on the development of new technologies, acquisition of small and medium-sized companies and exclusive product licensing to hold their strong position in the market. Besides, new product development, partnerships, distribution agreements are the other strategies followed by the leading market players to dominate themselves in the specialty active pharmaceutical ingredients (API) market.
For instance, in June 2016, Anacor Pharmaceuticals, Inc. a leading pharmaceutical company involved in developing small molecule therapeutics API was acquired by Pfizer Inc.
Small Molecules Segment Remains Key in Specialty Active Pharmaceutical Ingredients (API) Market
Increasing adoption of small molecules (non-biologics) owing to patent expiry and large number of generic drugs in development has resulted in affordable healthcare expenditure which is expected to drive the specialty active pharmaceutical ingredients (API) market.
Growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular, and the infectious diseases is also providing potential opportunities to the market player for developing small molecule APIs in specialty active pharmaceutical ingredients (API) market.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Complex Manufacturing Process and Stringent Regulations: Key Challenges for Specialty Active Pharmaceutical Ingredients (API) Market Players
Developing specialty active pharmaceutical ingredients can be complex due to the requirement of multiple production stages and the existence of limited patents of branded pharmaceuticals.
In addition, the stringent government regulations on quality assessment of specialty APIs and increase in supply chain security issues in the emerging countries imposing large impact on the cost of specialty APIs hence expected to hamper the growth of specialty active pharmaceutical ingredients (API) market. As such, the new entrants willing to enter the specialty active pharmaceutical ingredients market are facing financial challenges.
Type II DMFs to Keep the Cash Registers Ringing
Specialty API Market is shifting from Type I DMFs (Drug Master Files) to Type II DMFs Type II DMF drug documents drug substances, substance materials and intermediates used in drug product’s penetration. Extensive DMF filings could be credited to growing investments by Asia-Pacific-based players. Also, SAHPRA, Brazilian Health Regulatory Agency, MHRA, TGA, and U.S. FDA are into approvals of DMFs; thereby driving the market altogether.
Specialty Active Pharmaceutical Ingredients (API): Region-wise Analysis
Europe, followed by North America, continues to be the most lucrative market for specialty active pharmaceutical ingredients (APIs) due to high adoption rate of innovative/patented medicines. The U. S. remains most lucrative country in global specialty active pharmaceutical ingredients (API) market and it has consistently shown significant annual growth rates, and the market is set to grow at over 5.5% in 2020.
Outside of Europe and North America, Japan, China, India and GCC Countries represent significant opportunities for specialty active pharmaceutical ingredients (API) market players. The high patient population and growing demand for affordable healthcare facilities are expected to provide huge opportunities for the manufacturers to expand their business in this region. These economies like India and China are at the forefront on the count of adopting generics. Latin America is encouraging incorporation of novel regional players; which is expected to have specialty APIs as placeholders herein.
Contract manufacturing is also picking up across all the geographies. North America and Oceania are already in the saturation mode. There is more occurrence of chronic diseases in South Asia, East Asia, and MEA. This is another factor expected to create a major overhaul here.
Leading Players in Specialty Active Pharmaceutical Ingredients (API) Market
The specialty active pharmaceutical ingredients (API) market is witnessing a gradual entry of new players at a local or regional level. An estimated 20+ specialty active pharmaceutical ingredients (API) market players are actively involved in research and developments, technological advancement, and e-commerce to hold a distinct market identity. Some of the key players in the specialty active pharmaceutical ingredients (API) market are,
Americas
- Inalco Pharmaceuticals
- Sussex Research Laboratories Inc.
- PolyPeptide Laboratories
- Nitto Denko Avecia Inc.
- Dalton Pharma Services
- Amneal Pharmaceuticals, Inc.
- Mylan NV
Europe
- Corden Pharma International GmbH
- Pepscan Holding NV
- Provence Technologies Group
- BCN Peptides S.A.
- Senn Chemicals AG.
- Santaris Pharma A/S
- Sanofi
- Pfizer Inc.
- Jazz Pharmaceuticals, Inc.
Asia Pacific
- ST Pharm. Co. Ltd
- Symbiotec Pharma Lab Pvt. Ltd.
- Cadila Healthcare Ltd.
- Lupin Ltd.
- Amneal Pharmaceuticals, Inc.
They do operate all across “Specialty” and “Generics”. The company is known for APIs’ captive manufacturing for their own set of finished products.
- Cadila Healthcare Ltd.
The company is known for having offered 38 intermediates and APIs across therapeutic categories.
- Jazz Pharmaceuticals Plc
The company’s unified business segment does pave the way for a broad spectrum of APIs to produce finished products.
- Lupin Ltd.
The company produces as well as commercializes finished pharmaceutical products and offers APIs for these products.
- Mylan NV
The business segments Mylan caters to includes Rx/Bx, Gx, and OTC. The products for which it offers APIs address therapeutic areas like proton pump inhibitors, anti-fungals, anti-diebetics, anti-virals, cardiovascular, anti-asthamatics/anti-histamines, central nervous system agents, anti-bacterials, and HIV/AIDs.
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report
Specialty Active Pharmaceutical Ingredients (API): The Way Forward
The long-term outlook on specialty active pharmaceutical ingredients (API) market remains bullish, with FMI’s analysis estimating revenues to grow at over 7.0% consistently. The global increase in the patient pool having chronic ailments and rising infectious diseases around the world has created huge long-term demand of the small molecule active pharmaceutical ingredients (API) in the specialty active pharmaceutical ingredients (API) global market. Plus, growing demand for generic drugs is also expected to gain traction in the long-term market opportunities.
Specialty active pharmaceutical ingredients (API) manufacturers will need to focus on cost management and product sale and distribution to target wider geography. Portfolio strengthening and development of specialty active pharmaceutical ingredients (API) for wider application such in the pediatric and geriatric patient base are the key strategies needed to be focused by the leading industry players. In addition, to increase sales in lucrative markets, collaborations with local manufacturers is much needed.
Key Segments of Specialty Active Pharmaceutical Ingredients (API) Market
Product Type:
- Small Molecules API
- Controlled Substances API
- HPAPI
- Peptides API
- Carbohydrate Drugs API
- Steroidal Drugs API
Consumption:
- In-house
- Outsourced
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Frequently Asked Questions
The specialty-active pharmaceutical ingredients market is predicted to grow at 8.6% CAGR through 2032.
North America is likely to lead the specialty-active pharmaceutical ingredients market.
The specialty-active pharmaceutical ingredients market is expected to surpass US$ 478.52 Bn by 2032.
The specialty-active pharmaceutical ingredients market size is anticipated to be over US$ 209.7 Bn in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
2.4. Detailed COVID19 Impact Analysis
2.4.1. Prevalence
2.4.2. Pipeline Vaccines
2.4.3. Pipeline Drugs
2.4.4. Impact on Healthcare Industry
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.2. Forecast Factors - Relevance & Impact
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. COVID19 Crisis Analysis
4.4.1. Current COVID19 Statistics and Probable Future Impact
4.4.2. Current GDP Projection and Probable Impact
4.4.3. Current Economic Projection as compared to 2008 Economic analysis
4.4.4. COVID19 and Impact Analysis
4.4.4.1. Revenue By Product Type
4.4.4.2. Revenue By Country
4.4.5. 2020 Market Scenario
4.4.6. Quarter by Quarter Forecast
4.4.7. Projected recovery Quarter
5. Market Context
5.1. Product USPs/ Features
5.2. Product Adoption / Usage Analysis
5.3. Regulatory Scenario, By Region
5.4. Supply-Chain Analysis
6. Global Specialty Active Pharmaceutical Ingredients (API) Market Value (US$ Mn) Analysis 2015–2019 and Forecast, 2020–2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015–2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2020–2030
7. Global Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015–2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020–2030
7.3.1. Small Molecules API
7.3.1.1. Controlled Substances API
7.3.1.2. HPAPI
7.3.2. Peptides API
7.3.3. Carbohydrate Drugs API
7.3.4. Steroidal Drugs API
7.4. Market Attractiveness Analysis By Product Type
8. Global Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030, by Consumption
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Consumption, 2015–2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Consumption, 2020–2030
8.3.1. In-house
8.3.2. Outsourced
8.4. Market Attractiveness Analysis By Consumption
9. Global Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030, by Region
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020–2030
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Product Type
10.3.3. By Consumption
10.4. Market Attractiveness Analysis
10.5. Key Market Participants - Intensity Mapping
10.6. Drivers and Restraints - Impact Analysis
11. Latin America Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Argentina
11.3.1.4. Rest of Latin America
11.3.2. By Product Type
11.3.3. By Consumption
11.4. Market Attractiveness Analysis
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. Europe Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. BENELUX
12.3.1.7. Russia
12.3.1.8. Rest of Europe
12.3.2. By Product Type
12.3.3. By Consumption
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. South Asia Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
13.3.1. By Country
13.3.1.1. India
13.3.1.2. Thailand
13.3.1.3. Indonesia
13.3.1.4. Malaysia
13.3.1.5. Rest of South Asia
13.3.2. By Product Type
13.3.3. By Consumption
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. East Asia Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product Type
14.3.3. By Consumption
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Oceania Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.2. By Product Type
15.3.3. By Consumption
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020–2030
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Turkey
16.3.1.3. South Africa
16.3.1.4. Rest of Middle East and Africa
16.3.2. By Product Type
16.3.3. By Consumption
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Key and Emerging Countries Specialty Active Pharmaceutical Ingredients (API) Market Analysis 2015–2019 and Forecast 2020–2030
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.2.1. By Product Type
17.2.2. By Consumption
17.3. Canada Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.3.1. By Product Type
17.3.2. By Consumption
17.4. Mexico Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.4.1. By Product Type
17.4.2. By Consumption
17.5. Brazil Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.5.1. By Product Type
17.5.2. By Consumption
17.6. U.K. Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.6.1. By Product Type
17.6.2. By Consumption
17.7. Germany Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.7.1. By Product Type
17.7.2. By Consumption
17.8. France Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.8.1. By Product Type
17.8.2. By Consumption
17.9. Italy Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.9.1. By Product Type
17.9.2. By Consumption
17.10. Spain Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.10.1. By Product Type
17.10.2. By Consumption
17.11. BENELUX Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.11.1. By Product Type
17.11.2. By Consumption
17.12. Russia Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.12.1. By Product Type
17.12.2. By Consumption
17.13. China Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.13.1. By Product Type
17.13.2. By Consumption
17.14. Japan Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.14.1. By Product Type
17.14.2. By Consumption
17.15. South Korea Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.15.1. By Product Type
17.15.2. By Consumption
17.16. India Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.16.1. By Product Type
17.16.2. By Consumption
17.17. ASEAN Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.17.1. By Product Type
17.17.2. By Consumption
17.18. Australia Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.18.1. By Product Type
17.18.2. By Consumption
17.19. New Zealand Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.19.1. By Product Type
17.19.2. By Consumption
17.20. GCC Countries Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.20.1. By Product Type
17.20.2. By Consumption
17.21. Turkey Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.21.1. By Product Type
17.21.2. By Consumption
17.22. South Africa Specialty Active Pharmaceutical Ingredients (API) Market Analysis
17.22.1. By Product Type
17.22.2. By Consumption
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
18.3.1. Regional Footprint by Players
18.3.2. Product Foot print by Players
18.3.3. Channel Foot Print by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive (Tentative List)
19.3.1. Corden Pharma International GmbH
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
19.3.1.4. Sales Footprint
19.3.1.5. Strategy Overview
19.3.1.5.1. Marketing Strategy
19.3.1.5.2. Product Strategy
19.3.1.5.3. Channel Strategy
19.3.2. Pepscan Holding NV
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
19.3.2.4. Sales Footprint
19.3.2.5. Strategy Overview
19.3.2.5.1. Marketing Strategy
19.3.2.5.2. Product Strategy
19.3.2.5.3. Channel Strategy
19.3.3. Provence Technologies Group
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
19.3.3.4. Sales Footprint
19.3.3.5. Strategy Overview
19.3.3.5.1. Marketing Strategy
19.3.3.5.2. Product Strategy
19.3.3.5.3. Channel Strategy
19.3.4. BCN Peptides S.A.
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
19.3.4.4. Sales Footprint
19.3.4.5. Strategy Overview
19.3.4.5.1. Marketing Strategy
19.3.4.5.2. Product Strategy
19.3.4.5.3. Channel Strategy
19.3.5. Senn Chemicals AG.
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
19.3.5.4. Sales Footprint
19.3.5.5. Strategy Overview
19.3.5.5.1. Marketing Strategy
19.3.5.5.2. Product Strategy
19.3.5.5.3. Channel Strategy
19.3.6. Santaris Pharma A/S
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
19.3.6.4. Sales Footprint
19.3.6.5. Strategy Overview
19.3.6.5.1. Marketing Strategy
19.3.6.5.2. Product Strategy
19.3.6.5.3. Channel Strategy
19.3.7. Sanofi
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
19.3.7.4. Sales Footprint
19.3.7.5. Strategy Overview
19.3.7.5.1. Marketing Strategy
19.3.7.5.2. Product Strategy
19.3.7.5.3. Channel Strategy
19.3.8. Pfizer Inc.
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
19.3.8.4. Sales Footprint
19.3.8.5. Strategy Overview
19.3.8.5.1. Marketing Strategy
19.3.8.5.2. Product Strategy
19.3.8.5.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Expenditure on Health (% of GDP) by Country, 2016-2021
Table 2: Expenditure on Health (% of GDP) by Country, 2016-2021
Table 3: Global Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 5: Global Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Table 6: Global Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
Table 7: North America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 8: North America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 9: North America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Table 10: Latin America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 11: Latin America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 12: Latin America Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Table 13: Europe Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 14: Europe Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 15: Europe Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Table 16: South Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 17: South Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 18: South Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Table 19: East Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 20: East Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 21: East Asia Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Table 22: Oceania Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 23: Oceania Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 24: Oceania Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Table 25: MEA Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
Table 26: MEA Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
Table 27: MEA Specialty API Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Consumption
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Specialty API Market Historical Market Volume (Mn Units) Analysis, 2015-2019
Figure 2: Global Specialty API Current and Future Market Volume (Mn Units), 2020-2030 & Y-o-Y Growth Trend Analysis
Figure 3: Global Specialty API Market Historical Market Value (US$ Mn) Analysis, 2015-2019
Figure 4: Global Specialty API Current and Future Market Value (US$ Mn), 2020-2030 & Y-o-Y Growth Trend Analysis
Figure 5: Specialty API Market Absolute $ Opportunity, 2014–2029
Figure 6: Global Specialty API Market Share Analysis (%) By Product Type, 2020 & 2030
Figure 7: Global Specialty API Market Y-o-Y Growth (%) By Product Type, 2020-2030
Figure 8: Global Specialty API Market Attractiveness Analysis, By Product Type
Figure 9: Global Specialty API Market Share Analysis (%) By Consumption, 2020 & 2030
Figure 10: Global Specialty API Market Y-o-Y Growth (%) By Consumption, 2020-2030
Figure 11: Global Specialty API Market Attractiveness Analysis, By Consumption
Figure 12: Global Specialty API Market Share Analysis (%) By Region, 2020 & 2030
Figure 13: Global Specialty API Market Y-o-Y Growth (%) By Region, 2020-2030
Figure 14: Global Specialty API Market Attractiveness Analysis, By Region
Figure 15: North America Specialty API Market Share, By Product Type (2019)
Figure 16: North America Specialty API Market Share, By Consumption (2019)
Figure 17: North America Specialty API Market Share, By Country (2019)
Figure 18: North America Specialty API Market size (US$ Mn) 2020 & 2030
Figure 19: North America Specialty API Market Value (US$ Mn) Analysis, 2015–2019
Figure 20: North America Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030
Figure 21: North America Specialty API Market Attractiveness Analysis, By Product Type
Figure 22: North America Specialty API Market Attractiveness Analysis, By Consumption
Figure 23: North America Specialty API Market Attractiveness Analysis, By Country
Figure 24: Latin America Specialty API Market Share, By Product Type (2019)
Figure 25: Latin America Specialty API Market Share, By Consumption (2019)
Figure 26: Latin America Specialty API Market Share, By Country (2019)
Figure 27: Latin America Specialty API Market size (US$ Mn) 2020 & 2030
Figure 28: Latin America Specialty API Market Value (US$ Mn) Analysis, 2015–2019
Figure 29: Latin America Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030
Figure 30: Latin America Specialty API Market Attractiveness Analysis, By Product Type
Figure 31: Latin America Specialty API Market Attractiveness Analysis, By Consumption
Figure 32: Latin America Specialty API Market Attractiveness Analysis, By Country
Figure 33: Europe Specialty API Market Share, By Product Type (2019)
Figure 34: Europe Specialty API Market Share, By Consumption (2019)
Figure 35: Europe Specialty API Market Share, By Country (2019)
Figure 36: Europe Specialty API Market size (US$ Mn) 2020 & 2030
Figure 37: Europe Specialty API Market Value (US$ Mn) Analysis, 2015–2019
Figure 38: Europe Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030
Figure 39: Europe Specialty API Market Attractiveness Analysis, By Product Type
Figure 40: Europe Specialty API Market Attractiveness Analysis, By Consumption
Figure 41: Europe Specialty API Market Attractiveness Analysis, By Country
Figure 42: South Asia Specialty API Market Share, By Product Type (2019)
Figure 43: South Asia Specialty API Market Share, By Consumption (2019)
Figure 44: South Asia Specialty API Market Share, By Country (2019)
Figure 45: South Asia Specialty API Market size (US$ Mn) 2020 & 2030
Figure 46: South Asia Specialty API Market Value (US$ Mn) Analysis, 2015–2019
Figure 47: South Asia Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030
Figure 48: South Asia Specialty API Market Attractiveness Analysis, By Product Type
Figure 49: South Asia Specialty API Market Attractiveness Analysis, By Consumption
Figure 50: South Asia Specialty API Market Attractiveness Analysis, By Country
Figure 51: East Asia Specialty API Market Share, By Product Type (2019)
Figure 52: East Asia Specialty API Market Share, By Consumption (2019)
Figure 53: East Asia Specialty API Market Share, By Country (2019)
Figure 54: East Asia Specialty API Market size (US$ Mn) 2020 & 2030
Figure 55: East Asia Specialty API Market Value (US$ Mn) Analysis, 2015–2019
Figure 56: East Asia Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030
Figure 57: East Asia Specialty API Market Attractiveness Analysis, By Product Type
Figure 58: East Asia Specialty API Market Attractiveness Analysis, By Consumption
Figure 59: East Asia Specialty API Market Attractiveness Analysis, By Country
Figure 60: Oceania Specialty API Market Share, By Product Type (2019)
Figure 61: Oceania Specialty API Market Share, By Consumption (2019)
Figure 62: Oceania Specialty API Market Share, By Country (2019)
Figure 63: Oceania Specialty API Market size (US$ Mn) 2020 & 2030
Figure 64: Oceania Specialty API Market Value (US$ Mn) Analysis, 2015–2019
Figure 65: Oceania Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030
Figure 66: Oceania Specialty API Market Attractiveness Analysis, By Product Type
Figure 67: Oceania Specialty API Market Attractiveness Analysis, By Consumption
Figure 68: Oceania Specialty API Market Attractiveness Analysis, By Country
Figure 69: MEA Specialty API Market Share, By Product Type (2019)
Figure 70: MEA Specialty API Market Share, By Consumption (2019)
Figure 71: MEA Specialty API Market Share, By Country (2019)
Figure 72: MEA Specialty API Market size (US$ Mn) 2020 & 2030
Figure 73: MEA Specialty API Market Value (US$ Mn) Analysis, 2015–2019
Figure 74: MEA Specialty API Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2030
Figure 75: MEA Specialty API Market Attractiveness Analysis, By Product Type
Figure 76: MEA Specialty API Market Attractiveness Analysis, By Consumption
Figure 77: MEA Specialty API Market Attractiveness Analysis, By Country
Figure 78: U.S. Specialty API Market size (US$ Mn) 2020 & 2030
Figure 79: U.S. Specialty API Market Share, By Product Type (2019)
Figure 80: U.S. Specialty API Market Share, By Product Type (2019)
Figure 81: Brazil Specialty API Market size (US$ Mn) 2020 & 2030
Figure 82: Brazil Specialty API Market Share, By Product Type (2019)
Figure 83: Brazil Specialty API Market Share, By Product Type (2019)
Figure 84: Germany Specialty API Market size (US$ Mn) 2020 & 2030
Figure 85: Germany Specialty API Market Share, By Product Type (2019)
Figure 86: Germany Specialty API Market Share, By Product Type (2019)
Figure 87: U.K. Specialty API Market size (US$ Mn) 2020 & 2030
Figure 88: U.K. Specialty API Market Share, By Product Type (2019)
Figure 89: U.K. Specialty API Market Share, By Product Type (2019)
Figure 90: India Specialty API Market size (US$ Mn) 2020 & 2030
Figure 91: India Specialty API Market Share, By Product Type (2019)
Figure 92: India Specialty API Market Share, By Product Type (2019)
Figure 93: China Specialty API Market size (US$ Mn) 2020 & 2030
Figure 94: China Specialty API Market Share, By Product Type (2019)
Figure 95: China Specialty API Market Share, By Product Type (2019)
Figure 96: Japan Specialty API Market size (US$ Mn) 2020 & 2030
Figure 97: Japan Specialty API Market Share, By Product Type (2019)
Figure 98: Japan Specialty API Market Share, By Product Type (2019)
Figure 99: GCC Countries Specialty API Market size (US$ Mn) 2020 & 2030
Figure 100: GCC Countries Specialty API Market Share, By Product Type (2019)
Figure 101: GCC Countries Specialty API Market Share, By Product Type (2019)
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
